Top compounds associated with response to ERAL1


Feature Type Standardized
Nominal ANOVA
mRNA linifanib CTRPv2 pan-cancer AAC 0.048 0.2
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.05 0.2
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.2
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
mRNA MST-312 CTRPv2 pan-cancer AAC 0.046 0.2
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.045 0.2
mRNA JQ-1 GDSC1000 pan-cancer AAC 0.042 0.2
mRNA Doxorubicin FIMM pan-cancer AAC -0.18 0.2
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.046 0.2
mRNA KU-0063794 CTRPv2 pan-cancer AAC 0.046 0.2
Download CSV